Related Experiment Video
Updated: May 26, 2026

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
Published on: January 7, 2019
Exome sequencing identifies MPL as a causative gene in familial aplastic anemia
Amanda J Walne1, Arran Dokal, Vincent Plagnol
1Centre for Paediatrics, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, UK. a.walne@qmul.ac.uk
Abstract:
The primary cause of aplastic anemia remains unknown in many patients. The aim of this study was to clarify the genetic cause of familial aplastic anemia. Genomic DNA of an affected individual from a multiplex consanguineous family was hybridized to a Nimblegen exome library before being sequenced on a GAIIx genome analyzer. Once the disease causing homozygous mutation had been confirmed in the consanguineous family, this gene was then analyzed for mutation in 33 uncharacterized index cases of aplastic anemia (<13 years) using denaturing HPLC. Abnormal traces were confirmed by direct sequencing. Exome sequencing identified a novel homozygous nonsense mutation in the thrombopoietin receptor gene MPL. An additional novel homozygous MPL mutation was identified in the screen of 33 aplastic anemia patients. This study shows for the first time a link between homozygous MPL mutations and familial aplastic anemia. It also highlights the important role of MPL in trilineage hematopoiesis.
Insights
Genetic mutations in the thrombopoietin receptor gene MPL are linked to familial aplastic anemia. This discovery sheds light on the crucial role of MPL in blood cell formation.
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Aplastic anemia is a serious blood disorder where the bone marrow fails to produce enough blood cells.
- The genetic underpinnings of familial aplastic anemia are often not fully understood, necessitating further research into causative mutations.
Purpose of the Study:
- To investigate and identify the specific genetic cause of familial aplastic anemia.
- To explore the role of the thrombopoietin receptor gene (MPL) in the pathogenesis of this condition.
Main Methods:
- Exome sequencing was performed on DNA from an affected individual in a multiplex consanguineous family.
- Identified mutations were subsequently screened in 33 pediatric aplastic anemia cases using denaturing HPLC and direct sequencing.
Main Results:
- A novel homozygous nonsense mutation in the thrombopoietin receptor gene (MPL) was identified through exome sequencing.
- An additional novel homozygous MPL mutation was discovered in the cohort of aplastic anemia patients.
- Homozygous MPL mutations were found to be associated with familial aplastic anemia for the first time.
Conclusions:
- This study establishes a direct link between homozygous MPL mutations and familial aplastic anemia.
- The findings underscore the critical importance of the MPL gene in maintaining trilineage hematopoiesis (production of red blood cells, white blood cells, and platelets).
More Related Videos
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...